OA
AMGN icon

Operose Advisors’s Amgen AMGN Stock Holding History

Operose Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Hold
73
– – 0.01% 363
2026
Q1 		$25.7K Hold
73
– – 0.01% 339
2025
Q4 		$23.9K Sell
73
-18
-20% -$5.71K 0.01% 334
2025
Q3 		$25.7K Sell
91
-3
-3% -$870 0.01% 307
2025
Q2 		$26.2K Buy
94
+21
+29% +$5.95K 0.01% 278
2025
Q1 		$22.7K Buy
73
+70
+2,333% +$20.7K 0.01% 276
2024
Q4 		$782 Sell
3
-98
-97% -$29.1K ﹤0.01% 410
2024
Q3 		$32.5K Buy
101
+24
+31% +$7.85K 0.01% 328
2024
Q2 		$24.1K Hold
77
– – 0.01% 331
2024
Q1 		$21.9K Hold
77
– – 0.01% 373
2023
Q4 		$22.2K Sell
77
-77
-50% -$21K 0.01% 348
2023
Q3 		$41.4K Buy
154
+74
+93% +$18.5K 0.02% 343
2023
Q2 		$17.8K Hold
80
– – 0.01% 244
2023
Q1 		$19.3K Hold
80
– – 0.01% 227
2022
Q4 		$21K Hold
80
– – 0.01% 217
2022
Q3 		$18K Buy
+80
New +$19.4K 0.01% 223

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Operose Advisors's AMGN Position: Q2 2026 in Review

Operose Advisors held its Amgen (AMGN) position steady in Q2 2026 at 73 shares worth $26.4K. The position accounts for 0.01% of the portfolio, ranked #363.

Operose Advisors first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $41.4K in Q3 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Operose Advisors held 73 shares of Amgen worth $26.4K as of Q2 2026.
  • Operose Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.01% of Operose Advisors's portfolio in Q2 2026, its #363 holding.
  • Operose Advisors first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • Operose Advisors's Amgen position peaked at $41.4K in Q3 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.